| 價(jià)格 | 詢價(jià) |
| 包裝 | 1支 |
| 最小起訂量 | 1支 |
| 發(fā)貨地 | 湖北 |
| 更新日期 | 2026-07-30 |
| 中文名稱:重組人IGFBP-7 (C-6His)蛋白 | 英文名稱:Recombinant Human IGFBP-7 (C-6His) |
| 品牌: EnkiLife | 產(chǎn)地: 中國 |
| 保存條件: Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt.Reconstituted protein solution can be stored at 2-8°C for 2-7 days.Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. | 產(chǎn)品類別: 重組蛋白 |
| 是否進(jìn)口: 否 | 用途: 科研 |
| 產(chǎn)品名稱 |
Recombinant Human IGFBP-7 (C-6His) |
| 英文名稱 |
IGFBP-7/Igfbp7 |
| 純度 |
Greater than 95% as determined by reducing SDS-PAGE |
| 內(nèi)毒素 |
<1 EU/μg as determined by LAL test. |
| 蛋白構(gòu)建 |
Recombinant Human Insulin-like Growth Factor-binding Protein 7 is produced by our Mammalian expression system and the target gene encoding Ser27-Leu282 is expressed with a 6His tag at the C-terminus. |
| Accession |
Q16270 |
| 表達(dá)宿主 |
Human Cells |
| 種屬 |
Human |
| 預(yù)測(cè)分子量 |
27.3 KDa |
| 制劑 |
Lyophilized from a 0.2 μm filtered solution of 20mM Tris-HCl, 300mM NaCl, pH 8.0. |
| 運(yùn)輸方式 |
The product is shipped at ambient temperature.Upon receipt, store it immediately at the temperature listed below. |
| 穩(wěn)定性&儲(chǔ)存 |
Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt.Reconstituted protein solution can be stored at 2-8°C for 2-7 days.Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 復(fù)溶 |
Always centrifuge tubes before opening.Do not mix by vortex or pipetting.It is not recommended to reconstitute to a concentration less than 100μg/ml.Dissolve the lyophilized protein in distilled water.Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
| 分子別名 |
| Insulin-like growth factor-binding protein 7;IGFBP7;IGF-binding protein 7;IGFBP-rP1;MAC25 protein;Tumor-derived adhesion factor;TAF |
| 背景介紹 |
| Insulin-like growth factor-binding protein 7(IGFBP-7) is a secreted glycosylated protein that contains three protein domain modules. IGFBP7 contains an N-terminal IGFBP domain, followed by a Kazal-type serine proteinase inhibitor domain and a C-terminal immunoglobulin-like C2-type domain. Human and mouse IGFBP7 are highly homologous and share 94% aa sequence identity. It is expressed in many normal tissues and in cancer cells. It is abundantly expressed in high endothelial venules (HEVs) of blood vessels in the secondary lymphoid tissues. It binds IGF and insulin with very low affinity and has been shown to enhance the mitogenic actions of IGF and insulin. IGFBP7 also has IGF/insulin-independent activities. It interacts with heparan sulfate proteoglycans, type IV collagen, and specific chemokines. It supports weak cell adhesion, promotes cell spreading on type IV collagen, and stimulates the production of the potent vasodilator PGI2. It modulates tumor cell growth and has also been implicated in angiogenesis. |
注意事項(xiàng)
本司產(chǎn)品僅用于科研,不用于臨床診斷和治療
| 成立日期 | 2024-08-02 (3年) | 注冊(cè)資本 | 271萬人民幣 |
| 員工人數(shù) | 10-50人 | 年?duì)I業(yè)額 | ¥ 100萬-300萬 |
| 主營行業(yè) | 生化試劑,抗體,細(xì)胞培養(yǎng),癌癥研究,細(xì)胞生物學(xué) | 經(jīng)營模式 | 工廠,試劑,定制,服務(wù) |
| 產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
|---|---|---|---|---|
| ¥3200 |
VIP1年
|
上海研生實(shí)業(yè)有限公司
|
2026-08-04 | |
| 詢價(jià) |
VIP3年
|
北京百普賽斯生物科技股份有限公司
|
2026-06-30 | |
| ¥3000 |
VIP7年
|
上海澤葉生物科技有限公司
|
2026-08-04 |